These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2008919)

  • 1. Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer.
    Marsh GM; Leviton LC; Talbott EO; Callahan C; Pavlock D; Hemstreet G; Logue JN; Fox J; Schulte P
    Am J Ind Med; 1991; 19(3):291-301. PubMed ID: 2008919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
    Marsh GM; Cassidy LD
    Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation issues in the Drake Chemical Workers Notification and Health Registry Study.
    Leviton LC; Chen HT; Marsh GM; Talbott EO
    Am J Ind Med; 1993 Jan; 23(1):197-204. PubMed ID: 8422051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience.
    Marsh GM; Callahan C; Pavlock D; Leviton LC; Talbott EO; Hemstreet G
    J Occup Med; 1990 Sep; 32(9):881-6. PubMed ID: 2074513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drake Chemical Workers' Health Registry: coping with community tension over toxic exposures.
    Leviton LC; Marsh GM; Talbott E; Pavlock D; Callahan C
    Am J Public Health; 1991 Jun; 81(6):689-93. PubMed ID: 2029036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States.
    Stern FB; Murthy LI; Beaumont JJ; Schulte PA; Halperin WE
    J Occup Med; 1985 Jul; 27(7):495-500. PubMed ID: 4032086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine.
    Cassidy LD; Youk AO; Marsh GM
    Am J Ind Med; 2003 Sep; 44(3):282-90. PubMed ID: 12929148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer among chemical workers exposed to nitrogen products and other substances.
    Marsh GM; Gula MJ; Youk AO; Cassidy LD
    Am J Ind Med; 2002 Oct; 42(4):286-95. PubMed ID: 12271476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-beta-naphthylamine and o-toluidine.
    Sorahan T; Hamilton L; Jackson JR
    Occup Environ Med; 2000 Feb; 57(2):106-15. PubMed ID: 10711278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of occupational uroepithelial cancer].
    Hamasaki T; Aramaki K; Hida T; Inatomi H; Fujimoto N; Okamura T; Ozu K; Sugita A
    J UOEH; 1996 Dec; 18(4):247-59. PubMed ID: 8981648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder tumours in rubber workers: a factory study 1946-1995.
    Veys CA
    Occup Med (Lond); 2004 Aug; 54(5):322-9. PubMed ID: 15289589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant.
    Carreón T; Hein MJ; Hanley KW; Viet SM; Ruder AM
    Occup Environ Med; 2014 Mar; 71(3):175-82. PubMed ID: 24368697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing risk of bladder cancer among former workers at the last benzidine manufacturing facility in the USA.
    Millerick-May ML; Wang L; Rice C; Rosenman KD
    Occup Environ Med; 2021 Sep; 78(9):625-631. PubMed ID: 33972377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence in a chlorochemical plant in Isère, France: an occupational cohort study, 1979-2002.
    Bonneterre V; Mathern G; Pelen O; Balthazard AL; Delafosse P; Mitton N; Colonna M
    Am J Ind Med; 2012 Sep; 55(9):756-67. PubMed ID: 22692930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study.
    Naito S; Tanaka K; Koga H; Kotoh S; Hirohata T; Kumazawa J
    Cancer; 1995 Oct; 76(8):1445-52. PubMed ID: 8620422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of cancer from exposure to arylamines.
    Vineis P
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):7-10. PubMed ID: 7889862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan.
    Miyakawa M; Tachibana M; Miyakawa A; Yoshida K; Shimada N; Murai M; Kondo T
    Int J Urol; 2001 Aug; 8(8):423-30. PubMed ID: 11555006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers.
    Rosenman KD; Reilly MJ
    Am J Ind Med; 2004 Nov; 46(5):505-12. PubMed ID: 15490466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term impact of worker notification: qualitative assessment of a community-based notification and screening program in Augusta, Georgia.
    Needleman C; Connally LB
    Am J Ind Med; 2003 Aug; 44(2):113-23. PubMed ID: 12874843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis.
    Piolatto G; Negri E; La Vecchia C; Pira E; Decarli A; Peto J
    Br J Cancer; 1991 Mar; 63(3):457-9. PubMed ID: 2003988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.